Aesica -with- UCB SA (The pharmaceuticals sector) [2010] IECompA M10046 (20 December 2010)

Aesica -with- UCB SA (The pharmaceuticals sector) [2010] IECompA M10046 (20 December 2010)

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the pharmaceuticals sector and therefore cleared the transaction at Phase 1.

Citation
[2010] IECompA M10046
Parties
Acquirer: Aesica Pharmaceuticals Limited; Seller: UCB SA
Jurisdiction
Ireland
Judgment Date
20 December 2010
Procedural Posture
Merger Control / Clearance (phase 1)
Outcome
cleared
Legal Topics
Merger Control, Pharmaceutical Sector
Competition Law Merger Control Pharmaceutical Sector

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Aesica Pharmaceuticals Limited

Acquirer

UCB SA

Seller

Procedural Posture

Merger Control / Clearance (phase 1)

Legal Issues

  1. 1 Whether the proposed acquisition by Aesica Pharmaceuticals Limited of certain assets from UCB SA should be cleared under Irish competition law

Ratio Decidendi

The Competition Authority found that the proposed acquisition would not substantially lessen competition in the pharmaceuticals sector and therefore cleared the transaction at Phase 1.

Court Disposition

cleared

Orders

  • The proposed acquisition by Aesica Pharmaceuticals Limited of certain assets from UCB SA is cleared.